Detalhe da pesquisa
1.
IMPROVE: a feature model to predict neoepitope immunogenicity through broad-scale validation of T-cell recognition.
Front Immunol
; 15: 1360281, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38633261
2.
TCR-engaging scaffolds selectively expand antigen-specific T-cells with a favorable phenotype for adoptive cell therapy.
J Immunother Cancer
; 11(8)2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37586765
3.
Neoantigen-reactive CD8+ T cells affect clinical outcome of adoptive cell therapy with tumor-infiltrating lymphocytes in melanoma.
J Clin Invest
; 132(2)2022 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34813506